治疗性阿菲雷斯:在患有脏疾病的儿童中是否安全?
Muhammed Doğukan Kalenderoğlu1, Elif Çomak2, Gülşah Kaya Aksoy2
1Department of Pediatrics, Faculty of Medicine, Akdeniz University, Antalya, Turkey. mdkalenderoglu@gmail.com.
Pediatric nephrology (Berlin, Germany)
|March 19, 2024
概括
儿科脏病患者的治疗性非 (TA) 通常是安全的,并发症仅发生在4.8%的会议中. 在这些治疗过程中观察到的最常见的不良事件是技术问题,例如血液流量不足.
科学领域:
- 儿科脏病学 儿科脏病学
- 医疗技术 医疗技术 医学技术
- 患者安全 患者安全
背景情况:
- 治疗性阿菲雷斯 (TA) 是儿童各种脏病的重要治疗方式.
- 了解TA在这个人群中的安全性概况对于优化患者护理至关重要.
- 这项研究解决了对小儿病中TA并发症的数据需求.
研究的目的:
- 确定患有脏疾病的儿童与治疗性非症相关的并发症的频率和类型.
- 为了确定特定的风险因素或患者群体,在TA期间出现不良事件的发病率较高.
主要方法:
- 对2007年至2022年期间接受TA的儿童 (≤18岁) 病历的回顾性审查.
- 排除具有不完整数据或非科诊断的患者.
- 分析了1214个TA疗程,包括治疗性血交换 (TPE) 和免疫吸附 (IA).
主要成果:
- 共有108名儿科患者接受了1214次TA治疗 (1147次TPE,67次IA).
- 在4.8%的疗程中出现并发症 (58/1214),4.6%的疗程由于不良事件而没有完成.
- 技术并发症 (41.4%),主要是流量不足,是最常见的,其次是过敏反应 (25.9%).
- 在3-6岁儿童中观察到更高的并发症率 (p=0.031).
结论:
- 在儿科脏病患者中,治疗性非与低的整体并发症率 (4.8%) 相关.
- 在这一群体中,技术问题是TA期间最常见的并发症.
- 年龄似乎是影响并发症发生率的一个因素,较年轻的儿童 (3-6岁) 经历的事件更多.
相关概念视频
Dialysis
309
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
309
Bone Marrow Sampling and Transplants
329
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
329
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K


